论文部分内容阅读
目的探讨ATP个体化治疗阵发性室上性心动过速(PSVT)的应用。方法对45例患者ATP从0.1mg/kg开始治疗。若无效,每间隔3分钟,以0.05mg/kg量递增,再次静脉推注。至0.25mg/kg,静脉推注无效后,改其他药转复。观察其有效剂量、终止时间、不良反应、转复时伴发的心律失常。结果0.1mg/kg组终止时间与其他组有统计学差异,p<0.05。0.25mg/kg组伴发的心律失常较高。结论0.15～0.2mg/kgATP治疗安全、有效、副作用少。
Objective To explore the application of ATP in the treatment of paroxysmal supraventricular tachycardia (PSVT). Methods 45 patients with ATP from 0.1mg / kg start treatment. If invalid, every 3 minutes, in increments of 0.05mg / kg, intravenous injection again. To 0.25mg / kg, intravenous bolus invalid, change other drugs to restore. Observed the effective dose, termination time, adverse reactions, recovery of arrhythmia associated with. Results 0.1mg / kg group termination time with other groups were statistically significant, p <0.05.0.25mg / kg group associated with higher arrhythmia. Conclusion 0.15 ~ 0.2mg / kg ATP therapy is safe and effective with few side effects.